Just out - Head & Neck Cancers: Essentials for Clinicians
Providing the most clinically relevant & updated information for optimal prevention, diagnosis & treatment.
News
Rare cancer sufferers given reprieve with new drug subsidy
Sufferers of a rare blood cell cancer will get cheap access to a new drug after an unprecedented move by the Australian government.
Rare cancers through the looking glass
Despite the rarity of each of the so far 198 types of rare cancers, they account for approximately 22% of all cancer cases diagnosed in EU each year. This estimate is higher than any single common cancer and represents a significant public health issue.
Male breast cancer is not congruent with the female disease
Differences between breast cancer in men and women are seen in their epidemiological risk factors, molecular profiles and response to systemic therapy.
Immune Cells Deliver Cancer Drugs to the Brain
Neutrophils loaded with the chemotherapy drug paclitaxel traverse the blood-brain barrier and kill residual cancer cells after tumor-resection surgery.
Century-Old Tumours Offer Rare Cancer Clues
DNA sequences from 100-year-old tumour samples could bolster childhood cancer research
New nanotechnology application for difficult-to-treat cancers
A new treatment combining shock waves with nanoparticles can successfully treat tumours that are difficult to target using conventional chemotherapy.
Updated 2017 Multiple Myeloma: ESMO Clinical Practice Guidelines now available
These updated ESMO Clinical Practice Guidelines cover the diagnosis and pathology/molecular biology, staging and risk assessment and response evaluation of multiple myeloma.
Improving treatment results with reference centres for rare cancers: Where do we stand?
The European Union is currently supporting an official EU call to organise a European network to pool knowledge and expertise